Accro Bioscience's AC-101 Tablets Join NMPA's Rare Disease Development Initiative #China #Suzhou #AC-101 #Accro_Bioscience #Blau_syndrome
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialAccro Bioscience's AC-101 Tablets Join NMPA's Rare Disease Development Initiative #China #Suzhou #AC-101 #Accro_Bioscience #Blau_syndrome